Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
Classifica tra le azioni #28063
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Prezzo delle azioni
$0.04020123
Capitalizzazione di mercato
$28.83M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-31.34%
Paese
AU
Scambia Microba Life Sciences Limited (MAP)

Categoria

Storico del prezzo dell'azione per Microba Life Sciences Limited (MAP)
Prezzo di chiusura più alto: $0.04 il 2026-08-01

Prezzo di chiusura più basso: $0.27 il 2022-04-01
Storico del prezzo dell'azione di Microba Life Sciences Limited dal 2022 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -0.56%
2025 -58.06%
2024 -14.98%
2023 -33.14%
2022 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$614.87 24.26%
US
$211.90 0.24%
US
$24.30 89.94%
CN
$323.81 101.57%
US
$566.78 -11.42%
US